Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ICER
Pharma
ICER chief lays out requirement for more IRA involvement
ICER’s president, Sarah Emond, is still waiting for a signal from the government before regularly getting involved in IRA's price negotiations.
Angus Liu
Jan 30, 2024 3:15pm
AbbVie's Humira, J&J's Darzalex top ICER's annual price-hike list
Dec 11, 2023 11:26am
Vertex's pricing won't affect bluebird's strategy on lovo-cel
Nov 7, 2023 3:20pm
ICER weighs in on Eliquis, Xarelto price negotiations at CMS
Oct 2, 2023 2:42pm
Pair of future SCD gene therapies priced fair at $1.35M - $2.05M
Jul 14, 2023 9:36am
ICER founder Steve Pearson to step down from drug price watchdog
Jun 29, 2023 10:26am